Flanagan Rehab: Abrupt Ativan Stop Caused Resident to Fall - IL
A consultant pharmacist who reviewed the case was direct about what happened. Stopping Ativan, a benzodiazepine, without gradually reducing the dose can cause withdrawal. That withdrawal can bring on seizures, altered mental status, dizziness, fainting, and unresponsiveness. The pharmacist, identified in the inspection report as V7, told investigators that from his clinical standpoint, the abrupt discontinuation caused the resident to become unresponsive and fall.
She fell. Then she went to the hospital.
The inspection, completed September 18, 2025, was triggered by a complaint. Federal investigators rated the violation at the "actual harm" level, meaning the harm was not theoretical. It had already happened to a real person before anyone filed the complaint, before anyone showed up with a clipboard.
The resident is identified in the report only as R1. What is known: she was on Ativan, a medication that the body can become dependent on, and that dependence means the drug cannot simply be switched off. Any physician managing a patient on a benzodiazepine long-term understands this. Tapering is not optional. It is how the drug is safely discontinued.
Nobody tapered R1.
The facility's own medication administration policy required that any changes in medication orders be documented in the resident's medical record and that medication administration records be kept current and accessible. Whether those records reflected what actually happened to R1's prescription, and when, is not detailed in the portion of the inspection report provided. What is detailed is the outcome: a woman became unresponsive, hit the ground, and left the building in an ambulance.
V7's statement is the clearest line in the report. He did not hedge. He said the abrupt stop caused R1 to become unresponsive and fall, resulting in hospital admission. That is a pharmacist, reviewing the clinical record, drawing a straight line between what the facility did and what happened to the resident.
Ativan, the brand name for lorazepam, is prescribed for anxiety, seizure disorders, and other conditions. In nursing home residents, it is sometimes used for agitation or sleep. Stopping it without a taper can trigger a rebound effect, the body's nervous system overcorrecting after being suppressed by the drug. The symptoms V7 described, seizures, altered mental status, dizziness, syncope, and unresponsiveness, are the textbook presentation of benzodiazepine withdrawal. They are also frightening to witness and dangerous to experience.
R1 experienced them.
Flanagan Rehabilitation and Health Care Center sits in Flanagan, a small city in central Illinois. The facility serves residents in rehabilitation and long-term care. The inspection that caught this violation was not a routine survey. Someone filed a complaint first.
The violation was cited under F0760, the federal tag covering medication errors that cause actual harm. It is not the most serious possible finding, which would be immediate jeopardy, a finding that harm is ongoing or likely to continue. But actual harm is not a paperwork citation. It means an inspector reviewed the evidence and concluded that a resident was hurt by what the facility did, or failed to do.
What remains unanswered in the available record is how the order to stop Ativan was generated, who signed it, and whether the prescribing physician understood the drug was being discontinued without a taper or whether the breakdown happened somewhere between the order and the administration record. The inspection report, as provided, does not resolve those questions. It resolves only the outcome.
R1 went to the hospital. The pharmacist said the facility caused it.
Full Inspection Report
The details above represent a summary of key findings. View the complete inspection report for Flanagan Rehabilitation and Health Care Center from 2025-09-18 including all violations, facility responses, and corrective action plans.
Additional Resources
Data source: This article is based on inspection data downloaded directly from the Centers for Medicare & Medicaid Services (CMS) via Medicare.gov. CMS releases inspection reports in bulk; we publish the findings as documented by state surveyors in the official Form CMS-2567 Statement of Deficiencies.
Plan of correction: The CMS report we receive does not include the facility's plan of correction. Facilities submit plans of correction separately to state survey agencies and those responses may not be reflected in CMS data at the time of publication. The absence of a plan of correction in our data does not mean one was not filed. Readers who want information about corrective steps taken are encouraged to contact the facility directly or their state survey agency.
Corrections may have occurred: Inspection reports reflect conditions observed on the date of the survey. Facilities may have implemented corrections, staffing changes, additional training, or other remediation since the report was issued. We report what CMS provides and encourage readers to seek current information from the facility.
Editorial process: Inspection findings are extracted from CMS source documents and synthesized using AI, reviewed for factual accuracy against the original report by our editorial team.
Professional review: All content reviewed by Christopher F. Nesbitt, Sr., NH EMT & BU-trained Paralegal.
Last verified: September 17, 2026 · Our methodology
Flanagan Rehabilitation and Health Care Center in FLANAGAN, IL was cited for violations during a health inspection on September 18, 2025.
A consultant pharmacist who reviewed the case was direct about what happened.
Health inspections identify deficiencies that facilities must correct. Violations range from minor documentation issues to serious safety concerns. Review the full report below for specific details and facility response.